198 related articles for article (PubMed ID: 35854780)
1. Analysis of Clinical, Serological, and Imaging Features of Autoimmune Pancreatitis and a Case-Control Study on Prognostic Factors in Response to Hormone Therapy.
Liu Z; Zhu K; Sun C; Shen Y; Qu S
Contrast Media Mol Imaging; 2022; 2022():4829467. PubMed ID: 35854780
[TBL] [Abstract][Full Text] [Related]
2. Persistent enlargement of the pancreatic gland after glucocorticoid therapy increases the risk of relapse in IgG4-related autoimmune pancreatitis.
Lu H; Peng L; Zhu L; Feng R; Zhou J; Liu Z; Li J; Luo X; Peng Y; Qin C; Fei Y; Zhao Y; Zeng X; Lai Y; Zhang W
Clin Rheumatol; 2022 Jun; 41(6):1709-1718. PubMed ID: 35175447
[TBL] [Abstract][Full Text] [Related]
3. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
4. Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
Miki M; Fujimori N; Oono T; Kawabe K; Ohno A; Matsumoto K; Teramatsu K; Tachibana Y; Ogawa Y
J Dig Dis; 2019 Mar; 20(3):152-158. PubMed ID: 30701685
[TBL] [Abstract][Full Text] [Related]
5. [Clinical observation of isolated immunoglobulin G4-related sclerosing cholangitis and immunoglobulin G4 sclerosing cholangitis combined autoimmune pancreatitis].
Jiang P; Lian M; Li B; Xiao X; Miao Q; Wang QX; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):415-419. PubMed ID: 30317753
[No Abstract] [Full Text] [Related]
6. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
[TBL] [Abstract][Full Text] [Related]
7. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis.
Kamisawa T; Okazaki K; Kawa S; Ito T; Inui K; Irie H; Nishino T; Notohara K; Nishimori I; Tanaka S; Nishiyama T; Suda K; Shiratori K; Tanaka M; Shimosegawa T;
J Gastroenterol; 2014 Jun; 49(6):961-70. PubMed ID: 24639058
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients.
Xin L; He YX; Zhu XF; Zhang QH; Hu LH; Zou DW; Jin ZD; Chang XJ; Zheng JM; Zuo CJ; Shao CW; Jin G; Liao Z; Li ZS
Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):642-8. PubMed ID: 25475868
[TBL] [Abstract][Full Text] [Related]
9. Relative Rise of Serum IgG4 Levels After Steroid Therapy for Autoimmune Pancreatitis Predicts the Likelihood of Relapse.
Suzuki D; Shimizu K; Tokushige K
Pancreas; 2018 Apr; 47(4):412-417. PubMed ID: 29517627
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategy for autoimmune pancreatitis.
Kamisawa T; Satake K
Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
[TBL] [Abstract][Full Text] [Related]
11. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.
Kubota K; Watanabe S; Uchiyama T; Kato S; Sekino Y; Suzuki K; Mawatari H; Iida H; Endo H; Fujita K; Yoneda M; Takahashi H; Kirikoshi H; Kobayashi N; Saito S; Sugimori K; Hisatomi K; Matsuhashi N; Sato H; Tanida E; Sakaguchi T; Fujisawa N; Nakajima A
J Gastroenterol; 2011 Jun; 46(6):834-42. PubMed ID: 21491208
[TBL] [Abstract][Full Text] [Related]
12. [The clinical characteristics of 32 patients with autoimmune pancreatitis].
Chen D; Cao H; Chen Y; Li Y; Yu C
Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):380-3. PubMed ID: 25146405
[TBL] [Abstract][Full Text] [Related]
13. Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.
Matsubayashi H; Ishiwatari H; Imai K; Kishida Y; Ito S; Hotta K; Yabuuchi Y; Yoshida M; Kakushima N; Takizawa K; Kawata N; Ono H
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905944
[TBL] [Abstract][Full Text] [Related]
14. [Relapsing autoimmune pancreatitis type 1: case report].
Ondrejková A; Kianička B; Nechutová H; Hruška L; Novotný I; Souček M
Vnitr Lek; 2017; 63(4):277-283. PubMed ID: 28520452
[TBL] [Abstract][Full Text] [Related]
15. A variant form of autoimmune pancreatitis successfully treated by steroid therapy, accompanied by von Meyenburg complex.
Miura H; Kitamura S; Yamada H
World J Gastroenterol; 2009 Feb; 15(5):622-7. PubMed ID: 19195067
[TBL] [Abstract][Full Text] [Related]
16. Short-term and long-term outcomes of autoimmune pancreatitis.
Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune pancreatitis in Hungary: a multicenter nationwide study.
Czakó L; Gyökeres T; Topa L; Sahin P; Takács T; Vincze A; Dubravcsik Z; Szepes A; Pap A; Földesi I; Terzin V; Tiszlavicz L; Wittmann T
Pancreatology; 2011; 11(2):261-7. PubMed ID: 21625197
[TBL] [Abstract][Full Text] [Related]
18. Focal IgG4-related autoimmune pancreatitis with distal choledochal adenocarcinoma: a rare case report.
Wang H; Yao L; Wang L; Sun X; Huang B
BMC Gastroenterol; 2021 Nov; 21(1):421. PubMed ID: 34758732
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics of autoimmune pancreatitis].
Kim MJ; Oh CR; Lee KT
Korean J Gastroenterol; 2010 Nov; 56(5):276-84. PubMed ID: 21099234
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis.
Naitoh I; Nakazawa T; Ohara H; Ando T; Hayashi K; Tanaka H; Okumura F; Miyabe K; Yoshida M; Sano H; Takada H; Joh T
Pancreas; 2010 Jan; 39(1):e1-5. PubMed ID: 19924018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
